Biotechnology
May 5, 2016
Biotech: Still An Innovation Engine Biotech had a tough second half of 2015, and a tough beginning to 2016; between July’s high last year, and the February 2016 low, the Nasdaq Biotechnology Index (NBI) registered a nearly 40 percent decline, with an uneven recovery thereafter. Read more…